Rheumatoid Arthritis: Defning Clinical and Ultrasound Deep Remission

5Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

The prognosis of patients with rheumatoid arthritis (RA) has improved substantially in the last two decades due to the appearance of biological therapies, but above all, due to the improvement in the strategy and management of the disease. Our goal in RA should be to achieve remission, or in its absence, the lowest inflammatory activity. Achieving remission will prevent from structural and functional damage highly associated with RA itself. Clinical remission is defined as the absence of significant signs and symptoms of inflammatory disease activity, as well as the abrogation of any signs of systemic inflammation. Currently, there are some controversies about remission. Which is the real remission? Which remission criteria should be used and when? Does clinical remission mean ultrasound remission? In the present review, we try to answer and put some light into it, focusing on clinical and ultrasound deep remission.

Cite

CITATION STYLE

APA

Corominas, H., Millan, A. M., & Diaz-Torne, C. (2020). Rheumatoid Arthritis: Defning Clinical and Ultrasound Deep Remission. Mediterranean Journal of Rheumatology, 31(4), 384–388. https://doi.org/10.31138/MJR.31.4.384

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free